PEAK6 Group’s Novartis NVS Stock Holding History

PEAK6 Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$2.25M	Buy	33,257 +20,423	+159%	+$1.41M	0.01%	1280
2018 Q1	$930K	Sell	12,834 -12,388	-49%	-$943K	﹤0.01%	2036
2017 Q4	$1.9M	Buy	25,222 +15,290	+154%	+$1.15M	0.01%	1444
2017 Q3	$764K	Sell	9,932 -82,138	-89%	-$6.2M	﹤0.01%	2197
2017 Q2	$6.89M	Buy	92,070 +88,834	+2,745%	+$6.3M	0.04%	540
2017 Q1	$215K	Buy	3,236 +446	+16%	+$29.7K	﹤0.01%	3017
2016 Q4	$182K	Sell	2,790 -23,659	-89%	-$1.53M	﹤0.01%	3443
2016 Q3	$1.87M	Sell	26,449 -88,722	-77%	-$6.47M	0.01%	1334
2016 Q2	$8.52M	Buy	115,171 +83,477	+263%	+$5.77M	0.07%	410
2016 Q1	$2.06M	Buy	31,694 +28,346	+847%	+$1.93M	0.02%	1139
2015 Q4	$258K	Sell	3,348 -5,692	-63%	-$452K	﹤0.01%	3213
2015 Q3	$745K	Sell	9,040 -3,013	-25%	-$268K	﹤0.01%	2506
2015 Q2	$1.06M	Hold	12,053	–	–	0.01%	2024
2015 Q1	$1.06M	Sell	12,053 -3,348	-22%	-$297K	0.01%	1821
2014 Q4	$1.28M	Buy	15,401 +4,018	+35%	+$333K	0.01%	1725
2014 Q3	$960K	Buy	+11,383	New	+$921K	0.01%	1861
2014 Q1	–	Sell	-28,681	Closed	-$2.06M	–	5242
2013 Q4	$2.06M	Sell	28,681 -2,567	-8%	-$178K	0.01%	1425
2013 Q3	$1.08M	Buy	31,248 +20,088	+180%	+$1.33M	0.01%	2095
2013 Q2	$707	Buy	+11,160	New	+$726K	﹤0.01%	2462

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

PEAK6 Group's NVS Position: Q2 2018 in Review

PEAK6 Group increased its Novartis (NVS) stake by 4,780% in Q2 2018, buying an estimated $666K and bringing the position to 9,857 shares worth $667K. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

PEAK6 Group first reported a position in NVS in Q2 2013 and has held it in 17 quarters since. The position peaked at $4.97M in Q3 2015. 987 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

PEAK6 Group held 9,857 shares of Novartis worth $667K as of Q2 2018.
PEAK6 Group bought 9,655 Novartis shares in Q2 2018, an estimated $666K.
Novartis made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2327 holding.
PEAK6 Group first reported a position in Novartis in Q2 2013 and has held it in 17 quarters since.
PEAK6 Group's Novartis position peaked at $4.97M in Q3 2015.
987 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.